baber/WOPTO huggingface dataset:
Patent NZ-535659-A (NZ)
Title: Child-resistant trigger sprayer
Inventor: GOOD ROBERT J
IPC: B65D47/34
Filed: 2004-09-30
Abstract: A trigger actuated liquid sprayer is disclosed, including a pump body, a discharge nozzle mounted on a forward end of the body for manual rotation about a central axis thereof between discharge open and closed positions, and a trigger lever movably mounted to the body for operating a pumping mechanism upon actuation thereof. A trigger cover is mounted on the sprayer to overlie a front face of the trigger lever in a first position for immobilizing trigger lever actuation. The trigger cover can be rotated to a second position from the first position for exposing the front face for facilitating a grasp of the trigger lever for manual actuation thereof for operating the pumping mechanism. The trigger cover can be latched with the trigger lever in the first position to prevent rotation of the trigger cover from the first position to thereby render the sprayer child-resistant.
Patent NZ-538521-A (NZ)
Title: 3,4-Di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands
Inventor: TAVERAS ARTHUR G
IPC: C07D333/36
Filed: 2003-07-30
Abstract: Disclosed are cyclobutenedione compounds of formula (IB), which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
Patent NZ-539230-A (NZ)
Title: Hip prosthesis comprising a shaft to be inserted into the femur
Inventor: KELLER ARNOLD
IPC: A61F2/00
Filed: 2004-01-14
Abstract: A hip prosthesis comprising a straight shaft (1) to be inserted into the femur. The proximal part (6) of said shaft to be inserted into the metaphyseal region of the femur comprises at least one projecting fin (8) having a medially steep flank (23) on the front and rear sides. The fin deviates away from the longitudinal direction (27) of the shaft and is upwardly inclined towards the femoral neck (2), at least over part of its length. In this way, when the shaft is driven into the bone, the bone substance surrounding the fin thickens and is able to absorb higher forces. The height of the fin decreases from the medial flank (23) thereof to the lateral edge (25) thereof.
Patent NZ-540546-A (NZ)
Title: Methods of using and compositions comprising (-)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide
Inventor: MULLER GEORGE W
IPC: A61K31/4035
Filed: 2003-11-17
Abstract: Enantiomerically pure (-)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide, pharmaceutically acceptable metabolites, polymorphs, salts, solvates, and clathrates thereof are disclosed. Methods of treating and/or preventing various diseases and disorders, such as those ameliorated by the reduction of levels of TNF-alpha or the inhibition of PDE4, are also described.
Patent NZ-546726-A (NZ)
Title: Fitments
Inventor: VON SPRECKELSEN HENNING
IPC: B65D5/74
Filed: 2004-06-25
Abstract: A fitment to provide a pour spout and a resealable closure for aseptic and extended-shelf-life cartons is disclosed. The fitment (2) has a base flange (4) and a pour spout (6) closed by a screw-on cap (8). The base flange has a barrier foil (30) made of aluminium foil coated on both sides with a plastic layer embedded in a receiving wall (32) surrounding the periphery of the base flange. The foil disc (30) is sealed to the underside of the base flange and to a removable part (10) which has a pull-ring (14) attached to it.
Patent NZ-552163-A (NZ)
Title: Identification system and method
Inventor: MAGDI NABIL
IPC: H04W12/06
Filed: 2005-05-20
Abstract: A method of a user obtaining access to secure information stored on a base station using an identification device is disclosed. The identification device includes a store including code data and at least one predetermined rule. In the identification device at least one algorithm is determined. Request data indicative of at least one parameter is received from the base station. Modified code data is generated using the at least one algorithm; the at least one parameter; and the code data. Ordered data is generated using the at least one predetermined rule; the at least one parameter; and the modified code data. Indicating data at least partially indicative of the ordered data is transferred to the base station, thereby allowing the base station to authenticate the user using the indicating data. Also disclosed is a method of a base station authenticating a user using an identification device for obtaining access to secure information stored on the base station. The identification device includes a store including: code data; and at least one predetermined rule. The base station includes a processor; and a data store including: the at least one predetermined rule; at least one parameter. In the base station request data at indicative of the at least one parameter is transferred to the identification device. Indicating data generated as described above is received from the identification device. The at least one algorithm used by the identification device is determined and the at least one algorithm is reversely applied to the indicating data using the at least one predetermined rule and the at least one parameter to generate the code data, thereby allowing the base station to authenticate the user.
Patent NZ-554412-A (NZ)
Title: Use of [D-MeAla]3-[EtVal]4-cyclosporin for the treatment of hepatitis C infection and pharmaceutical composition comprising said [D-MeAla]3-[EtVal]4-cyclosporin
Inventor: SCALFARO PIETRO
IPC: A61K38/13
Filed: 2005-10-03
Abstract: Disclosed is the use of [D-MeAla]3-[EtVal]4-CsA (cyclosporin) for the manufacture of a medicinal product intended for the treatment of hepatitis C (HCV) infection or the prevention of HCV recurrence, wherein EtVal is N-ethyl-L-valine.
Patent NZ-554581-A (NZ)
Title: Anti-fog refrigeration door and method of making the same
Inventor: CORDING CHRISTOPHER R
IPC: B61D17/12
Filed: 2005-09-20
Abstract: Disclosed is an anti-fog or anti-frost coating comprising a mixture of: i) a first component comprising about 46% diacetone alcohol, about 4% N-methyl Pyrrolidone, about 4% t-butanol, about 8% Cyclohexane, about 6% 2,4-pentanedione, and about 2% naptha; and ii) a second component comprising about 66% polyisocyanate, about 1% free monomeric isocyanates, about 11% xylene, about 11% n-butyl acetate, and about 11% toluene; wherein the mixture ratio of the first component to the second component is about 100:about 30-33 and wherein the mixture comprises a silane. Also disclosed is a refrigeration door having an outer surface and adapted to be mounted on a refrigerating compartment, said door comprising: a first sheet of glass; a second sheet of glass; a first sealant assembly disposed around the periphery of said first sheet of glass and said second sheet of glass for maintaining said first sheet and said second sheet in spaced apart relationship from each other; a first low emissivity coating adjacent a surface of said first sheet or said second sheet of glass; an anti-fog or anti-frost coating adjacent a surface of at least one of said sheets of glass; said first sheet and second sheets of glass, said first sealant assembly, and said first low emissivity coating forming an insulating glass unit having a U value substantially equal to or less than 0.2 BTU/hr-sq fr-F or an emissivity substantially equal to or less than 0.04; and a frame secured around the periphery of said insulating glass unit wherein the anti-fog or anti-frost coating comprises a first silane.
Patent NZ-573359-A (NZ)
Title: Method and system for scenario based training with consequences
Inventor: MITCHELL TRACY ANNE
IPC: G06Q50/00
Filed: 2008-12-03
Abstract: A processing system including a processor and a memory is configured to provide scenario based training or assessment of a user. The processing system comprises a display device to display scenario information about a scenario to the user and to display a scenario question and a plurality of answers to the user and a software application stored in the memory and executable by the processor. The software application is configured to receive a user selected answer, determine if the user selected answer is correct or incorrect; and determine first consequence information if the user selected answer is correct, or second consequence information if the user selected answer is incorrect. The user selected answer is selected from the plurality of answers and input by the user using an input device. The display device displays the first consequence information or the second consequence information to the user, and when the user selected answer is incorrect, the display device displays a different scenario question and a different plurality of answers to the user before again displaying the scenario question and at least some of the plurality of answers to the user.
Patent NZ-579443-A (NZ)
Title: Pharmaceutical formulations for sustained drug delivery
IPC: A61K38/095
Filed: 1997-12-11
Abstract: Provided is the use of a pharmaceutical formulation in the preparation of a medicament for treating a subject having a condition treatable by a pharmaceutically active peptidic compound, wherein the pharmaceutical formulation comprises a solid ionic complex of a pharmaceutically active peptidic compound and a carrier macromolecule, wherein the peptidic compound is not an LHRH analogue; wherein prior to complexing with the pharmaceutically active peptidic compound, the carrier molecule is water soluble; wherein the peptidic compound present within the pharmaceutical formulation is in excess relative to the carrier macromolecule on a weight/weight basis; and wherein the pharmaceutical composition is suitable for parenteral administration. The carrier can be carboxymethylcellulose.
Patent NZ-585092-A (NZ)
Title: Food material for inhibiting osteoclastogenesis
Inventor: SERIZAWA ATSUSHI
IPC: C07K2/00
Filed: 2008-10-28
Abstract: 585092 Provided is a milk protein fraction derived from milk, wherein the milk protein fraction contains proteins having a molecular weight of 80,000 to 85,000 daltons determined by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), contains 16 to 18wt% of basic amino acids in the constituent amino acid composition, has a basic amino acid/acidic amino acid ratio of 0.65 to 0.85, and has an osteoclastogenesis inhibitory effect.
Patent NZ-585854-A (NZ)
Title: Alkaline cleaning compositions
Inventor: BONNECHERE GENEVIEVE
IPC: C11D1/22
Filed: 2007-12-18
Abstract: Disclosed herein is a cleaning composition comprising: (i) a buffering system comprising a strong base having a pKa of 13 or above and an acid selected from an organic acid, phosphonic acid or phosphoric acid; (ii) an alkanolamine (preferably monoethanolamine, diethanolamine, triethanolamine or mixtures thereof); (iii) at least one surfactant chosen from a zwitterionic surfactant, a non-ionic surfactant, an anionic surfactant and mixtures thereof; and (iv) an organic solvent chosen from lower alkanols, glycol ethers and diethers, and mixtures thereof; wherein the pH of the composition is about 9 to about 13.
Patent NZ-593983-A (NZ)
Title: Triglyceride compositions useful for preparing composite panels
Inventor: WANTLING STEVEN J
IPC: C09K23/00
Filed: 2010-01-14
Abstract: Disclosed herein is a composite panel prepared using a moisture resistance additive useful for preparing composite panels, the composite panel comprising: gypsum, cellulose, or combinations thereof; and the moisture resistance additive, wherein the moisture resistance additive is provided as an emulsion comprising; a triglyceride having a saponification value of at least 150 and an iodine value of at least 35; at least one non-ionic emulsifier comprising a fatty acid ester of a polyalcohol; and water, wherein the moisture resistance additive is free of hydrocarbon wax. Also disclosed is a method for preparing said composite panel, A moisture resistance additive useful for preparing composite panels.
Patent NZ-595540-A (NZ)
Title: Heating-energy saving system for use with a heating system of a beverage machine
Inventor: KARLSSON MARTIN
IPC: A47J31/56
Filed: 2011-10-04
Abstract: Disclosed is a heating energy saving system (10) for use with a heating system (21) of a beverage machine (20). The energy saving system (10) is comprised of a timer (11), a plurality of data registers (12a-12x), a detection unit (13) and a control unit (14). Each of the data registers (12a-12x) is active within a predetermined range of time and can hold one of at least 2 values. The detection unit (13) is for detecting a usage of the beverage machine (20). The control unit (14) is adapted to determine the values of the plurality of data registers (12a-12x) and to change the value of the active data register upon a detection by the detection unit (13). The control unit (14) is further adapted to turn off the heating system (21) of the beverage machine (20) if it determines that the active data register holds a value equal to or lower than a threshold value. The control unit (14) is also adapted to turn on the heating system (21) of the beverage machine (20) if it determines that the active data register holds a value larger than the threshold value.
Patent NZ-596060-A (NZ)
Title: NOVEL CRYSTAL FORMS OF TRICYCLIC BENZOPYRAN COMPOUND AND PROCESSES FOR PRODUCING SAME; (3R,4S)-7-hydroxymethyl-2,2,9-trimethyl-4-(phenethylamino)-3,4-dihydro-2H-pyrano[2,3g]quinolin-3-ol
Inventor: TAKADA YASUTAKA
IPC: C07D491/052
Filed: 2010-04-30
Abstract: Disclosed is crystalline forms A, B, E, F, G and H of (3R,4S)-7-hydroxymethyl-2,2,9-trimethyl-4-(phenethylamino)-3,4-dihydro-2H-pyrano[2,3g]quinolin-3-ol. Also disclosed is a production method of the said polymorphs.
Patent NZ-597205-A (NZ)
Title: Recovery of butanol from a mixture of butanol, water and an organic extractant
Inventor: XU YIHUI TOM
IPC: C07C29/80
Filed: 2010-07-15
Abstract: Disclosed herein is a process for recovering butanol comprising the steps: introducing a feed comprising: a water-immiscible organic extractant, water, at least one isomer of butanol, and optionally a non-condensable gas into a first distillation column, wherein the first distillation column comprises a stripping section and optionally a rectifying section at an introduction point above the stripping section, the first distillation column having an operating temperature, T1 and an operating pressure P1 at a predetermined point in the stripping section, wherein T1 and P1 are selected to produce a first bottoms stream and a first vaporous overhead stream, the first bottoms stream comprising the water-immiscible organic extractant and butanol and being substantially free of water, and the first vaporous overhead stream comprising water, butanol, and the optional non-condensable gas; condensing the first vaporous overhead stream to produce an optional gas phase and recover a first mixed condensate, wherein the first mixed condensate comprises a butanol phase comprising butanol and less than about 30 wt% water; and an aqueous phase comprising water and less than about 10 wt% of butanol; introducing at least a portion of the butanol phase to the first distillation column; and introducing a first portion of the first bottoms stream into a second distillation column having at least a stripping section and optionally a rectifying section and operating the second distillation column to produce a second bottoms stream comprising the extractant and being substantially free of butanol, and a second vaporous overhead stream comprising butanol; wherein the extractant preferentially dissolves butanol over water and is separable from butanol by distillation.
Patent NZ-597746-A (NZ)
Title: Hydraulic ripper for excavators
Inventor: ARACAMA MARTINEZ DE LAHIDALGA JAVIER
IPC: A01B13/08
Filed: 2010-02-15
Abstract: The disclosure relates to a hydraulic ripper for excavators used to break up and remove hard elements from the ground, such as stone, concrete, asphalt or similar elements, which includes a shank (1) connected to the head (5) of the excavator by means of a plurality of attachment elements (6) and which includes at least one shank (1) with an actuator means (2, 3) secured to a battery (4), wherein the assembly of the shank (1), the actuator means (2, 3) and the battery (4) is secured to said shank (1) and positioned on the longitudinal axis (7) of the shank (1), and wherein said axis (7) is the axis on which the ground is ripped between the retracted (A) and extended (B) positions of the shank (1).
Patent NZ-600371-A (NZ)
Title: Uracil or thymine derivative for treating hepatitis c
Inventor: WAGNER ROLF
IPC: C07D417/10
Filed: 2008-09-17
Abstract: Disclosed are Uracil or Thymine derivatives of formula (I-L0). Examples of a compounds of formula (I) are: N-(6-(3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl) methanesulfonamide; N-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide; and N-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)quinolin-2-yl)methanesulfonamide. Also disclosed are pharmaceutical compositions comprising a compound of formula (I-L0); the use of a compound of formula (I-L0) in the manufacture of a medicament; and the process of making compounds of formula (I-L0) and the starting compound (where R6 of (I-L0) is halo). The medicament is useful in the treatment of Hepatitis C virus.
Patent NZ-600636-A (NZ)
Title: Wood preservative compositions useful for treating copper-tolerant fungi
Inventor: MARS CRAIG ANDREW
IPC: A01N33/12
Filed: 2011-06-21
Abstract: The disclosure relates to a method of protecting wood or other cellulosic material from decay by copper-tolerant fungi selected from the group consisting of Serpula himantioides, Antrodia spp, Gloeophyllum abietinum, Gloeophyllum sepiarium, Paxillus panuodes, Stereum hirsutum and Fomitopsis palustris, wherein the method fcomprising the step of applying to said wood or other cellulosic material a preservative composition comprisinga biocidal metal compound, a 1,2,4-triazole and a didecyl quaternary ammonium cation. Didecyldimethyl quaternary ammonium compounds are particularly preferred. The biocidal metal compound is preferably a copper compound selected from basic copper carbonate, copper (II) acetate, copper (II) sulphate pentahydrate, copper (II) hydroxide, copper (II) oxide, copper (I) oxide, copper-HDC, and copper pyrithione, or a zinc compound selected from zinc oxide, zinc carbonate, zinc borate and zinc pyrithione; and the 1,2,4-triazole is selected from triadimefon, triadimenol, triazbutil, propiconazole, cyproconazole, difenoconazole, fluquinconazole, tebuconazole, flusilazole, uniconazole, diniconazole, bitertanol, hexaconazole, azaconazole, flutriafol, epoxyconazole, tetraconazole, penconazole, ipconazole, prothioconazole, metcoazole and mixtures thereof.
Patent NZ-601551-A (NZ)
Title: Respiratory face mask and breathing circuit assembly
Inventor: NASHED RAMSES
IPC: A61M39/12
Filed: 2011-01-28
Abstract: A respiratory face mask (10) is provided suitably sized and configured to engage at least the nose portion and mouth portion of a patient’s face. Gas from a gas supply and scavenging set normally used in dentistry is operatively coupled to the mask via a breathing circuit (90) to supply fresh gas and evacuate exhaled waste gas, comrpising a single length of co-axial flexible tubing (136) connected between the face mask and a branched coupling (140). The branched coupling, in turn, includes a first branch for connection to the fresh gas supply nozzle of the “dental” set-up and a second branch for connection to a flexible flow-through reservoir bag (132, 176) used to store waste or exhaled gas. A one-way valve (172) is disposed between the second branch output nozzle and the input of the flexible bag. The output of the flexible flow-through bag is connected to the vacuum module of the “dental” set-up. The second branch of the coupling, the one-way valve, and the flexible flow-through reservoir bag define the exhalation limb of the breathing circuit.
Patent NZ-603813-A (NZ)
Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
Inventor: CHIANG KYLE P
IPC: A61P35/00
Filed: 2011-07-12
Abstract: A therapeutic composition, comprising an isolated amino acyl-tRNA synthetase (AARS) polypeptide of up to about 300 amino acids in length that comprises SEQ ID NO: 12 or 34 or an amino acid sequence that is at least 90% identical to SEQ ID NO: 12 or 34, wherein the AARS polypeptide has an extracellular signalling activity and a solubility of at least about 5 mg/mL, and wherein the composition has a purity of at least about 95% on a protein basis and less than about 10 EU endotoxin / mg protein.
Patent NZ-622767-A (NZ)
Title: Method and devices for determining the distance between a radio beacon and an onboard unit
Inventor: SMELY DIETER
IPC: G08G1/01
Filed: 2011-11-29
Abstract: Disclosed is a method for determining the distance between a radio beacon and an onboard unit passing the beacon in a road toll system. At least one of the two components, radio beacon and onboard unit, emits a signal with a known curve of its frequency over time. The method includes receiving the signal in the other of the two components during passage and recording the curve of its frequency over time in relation to the known curve over time and detecting a change in the recorded frequency curve exceeding a first threshold value. The method also includes looking for two far regions in the frequency curve lying before and after the detected change in time that show a frequency change below a second threshold value and scaling the recorded frequency curve in such a manner that the far regions assume predetermined values. The distance between the roadside beacon and the onboard unit is then determined from the scaled frequency curve, with the proviso that, when the signal is emitted by the onboard unit and received at the radio beacon, the distance is not determined from the gradient of the scaled frequency curve in an inflection point thereof.
Patent NZ-628423-A (NZ)
Title: Methods of treating cancer
Inventor: SOON-SHIONG PATRICK
IPC: A61P35/00
Filed: 2011-03-28
Abstract: Disclosed is the use of a composition comprising nanoparticles comprising paclitaxel and an albumin in the manufacture of a medicament for treatment of non-small cell lung cancer (NSCLC) in an individual, wherein the medicament is to be administered with an effective amount of a platinum-based agent such as carboplatin, wherein treatment is based upon the NSCLC having one or more characteristic selected from the group consisting of (i) differential levels of caveolin-1 (CAV1), (ii) differential levels of secreted protein acidic and rich in cysteine (SPARC), (iii) differential levels of hypoxia markers, (iv) differential levels of tumor acidity, (v) differential levels of gp60, (vi) differential levels of thymidylate synthase (TS), (vii) differential levels of S phase kinase-associated protein (Skp2), (viii) differential loss of heterozygosity (LOH) of single-nucleotide polymorphism (SNP), (ix) differential Kras mutations, (x) differential methylation of promoter region of tumor-related genes, and (xi) differential albumin uptake, wherein the treatment is based on the individual being at least about 70 years old.